Prostatype Genomics AB (publ)

DB:PGO Stock Report

Market Cap: €1.1m

Prostatype Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:PGO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Sep 24Sell€3,605Anders LundbergIndividual1,749,849€0.0021

Insider Trading Volume

Insider Buying: PGO insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of PGO?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,932,6800.195%
Institutions3,099,4060.313%
Individual Insiders9,409,5030.95%
General Public976,369,59798.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 729.4%.


Top Shareholders

Top 10 shareholders own 1.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.85%
Hakan Englund
8,461,519€9.7k1,100%no data
0.31%
Creathor Venture Management GmbH
3,079,911€3.5k0%no data
0.2%
Aj Lundberg KapitalfÖRvaltning Ab
1,932,680€2.2k-47.5%no data
0.064%
Michael Haggman
632,579€727.84,170%no data
0.018%
Fredrik Rickman
175,128€201.5-29.4%no data
0.01%
Jörgen Dahlström
100,000€115.00%no data
0.002%
FCG Fonder AB
19,495€22.50%no data
0.0019%
Michael Winklerfelt
18,848€21.70%no data
0.0012%
Emelie Berglund
11,478€13.20%no data
0.001%
Karlheinz Schmelig
9,951€11.40%no data